Evidence map›Paper›PMID 40678420›Full record

ArticleTurkish journal of biology = Turk biyoloji dergisi2025

Screening of CCDC43 molecular partners by BioID2-based proximity labeling.

Merve Tuzlakoğlu Öztürk

Abstract read
In one paragraph

Article in Turkish journal of biology = Turk biyoloji dergisi, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Merve Tuzlakoğlu ÖztürkDepartment of Molecular Biology and Genetics, Faculty of Science, Gebze Technical University, Gebze, Kocaeli, Turkiye.ORCID https://orcid.org/0000-0001-5983-2854

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background/aim: CCDC43 (coiled-coil domain containing protein 43) is a eukaryotic protein that contains alpha-helical domains in its structure, consistent with the family to which it belongs. It is predominantly located in the cytosol of the cell. CCDC43 protein has been shown to play a role in cell proliferation, invasion, metastasis, and epithelial-mesenchymal transition in gastric and colorectal cancer types. The fundamental function and cellular interaction network of this protein, which is known to have varying expression levels in various cancer types, has not yet been fully elucidated. Here, we conducted a proximity-dependent biotin identification (BioID2) screening approach for CCDC43 to uncover proximity interactors. Materials and methods: Using mass spectrometry of streptavidin pull-down of biotinylated proteins with filtering approaches, we identified candidate protein interactors for CCDC43. Results: We suggest an association between CCDC43 and RNA-binding proteins based on all our biological replicates. The strongest candidate for the interactome is YBX1, a highly conserved cold shock domain and nucleic acid-binding protein that has multiple essential functions in the cell. Conclusion: These findings suggest that CCDC43 may play a role in critical pathways within the cell.

Indexed as

BioIDCCDC43mass spectrometry

Identifiers

PMID40678420
PMCPMC12266347

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.